Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice
published in: Autoimmunity
date of publication: 2013-02-01
Cites articles
There is nothing here
Article - wd:Q87413120